BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 24878243)

  • 1. Inhibition of the microglial response is essential for the neuroprotective effects of Rho-kinase inhibitors on MPTP-induced dopaminergic cell death.
    Borrajo A; Rodriguez-Perez AI; Villar-Cheda B; Guerra MJ; Labandeira-Garcia JL
    Neuropharmacology; 2014 Oct; 85():1-8. PubMed ID: 24878243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of microglial RhoA/Rho-kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors.
    Villar-Cheda B; Dominguez-Meijide A; Joglar B; Rodriguez-Perez AI; Guerra MJ; Labandeira-Garcia JL
    Neurobiol Dis; 2012 Aug; 47(2):268-79. PubMed ID: 22542954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Rho Kinase Inhibitors on Grafts of Dopaminergic Cell Precursors in a Rat Model of Parkinson's Disease.
    Rodriguez-Pallares J; Rodriguez-Perez AI; Muñoz A; Parga JA; Toledo-Aral JJ; Labandeira-Garcia JL
    Stem Cells Transl Med; 2016 Jun; 5(6):804-15. PubMed ID: 27075764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-hydroxymorphinan is neurotrophic to dopaminergic neurons and is also neuroprotective against LPS-induced neurotoxicity.
    Zhang W; Qin L; Wang T; Wei SJ; Gao HM; Liu J; Wilson B; Liu B; Zhang W; Kim HC; Hong JS
    FASEB J; 2005 Mar; 19(3):395-7. PubMed ID: 15596482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rho Kinase and Dopaminergic Degeneration: A Promising Therapeutic Target for Parkinson's Disease.
    Labandeira-Garcia JL; Rodríguez-Perez AI; Villar-Cheda B; Borrajo A; Dominguez-Meijide A; Guerra MJ
    Neuroscientist; 2015 Dec; 21(6):616-29. PubMed ID: 25323761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secalonic acid A protects dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP⁺)-induced cell death via the mitochondrial apoptotic pathway.
    Zhai A; Zhu X; Wang X; Chen R; Wang H
    Eur J Pharmacol; 2013 Aug; 713(1-3):58-67. PubMed ID: 23665112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Rho kinase mediates the neuroprotective effects of estrogen in the MPTP model of Parkinson's disease.
    Rodriguez-Perez AI; Dominguez-Meijide A; Lanciego JL; Guerra MJ; Labandeira-Garcia JL
    Neurobiol Dis; 2013 Oct; 58():209-19. PubMed ID: 23774254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's disease.
    Tönges L; Frank T; Tatenhorst L; Saal KA; Koch JC; Szego ÉM; Bähr M; Weishaupt JH; Lingor P
    Brain; 2012 Nov; 135(Pt 11):3355-70. PubMed ID: 23087045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of dopaminergic neurons by 5-lipoxygenase inhibitor.
    Kang KH; Liou HH; Hour MJ; Liou HC; Fu WM
    Neuropharmacology; 2013 Oct; 73():380-7. PubMed ID: 23800665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine metabolites protect dopaminergic neurons through inhibition of microglial NADPH oxidase.
    Jiang L; Wu X; Wang S; Chen SH; Zhou H; Wilson B; Jin CY; Lu RB; Xie K; Wang Q; Hong JS
    J Neuroinflammation; 2016 May; 13(1):110. PubMed ID: 27184631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin-activated microglia contribute to death of dopaminergic neurons in rat mesencephalic cultures: dual roles of mitogen-activated protein kinase signaling pathways.
    Lee DY; Oh YJ; Jin BK
    Glia; 2005 Aug; 51(2):98-110. PubMed ID: 15789435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron Chelators and Antioxidants Regenerate Neuritic Tree and Nigrostriatal Fibers of MPP+/MPTP-Lesioned Dopaminergic Neurons.
    Aguirre P; Mena NP; Carrasco CM; Muñoz Y; Pérez-Henríquez P; Morales RA; Cassels BK; Méndez-Gálvez C; García-Beltrán O; González-Billault C; Núñez MT
    PLoS One; 2015; 10(12):e0144848. PubMed ID: 26658949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sinomenine, a natural dextrorotatory morphinan analog, is anti-inflammatory and neuroprotective through inhibition of microglial NADPH oxidase.
    Qian L; Xu Z; Zhang W; Wilson B; Hong JS; Flood PM
    J Neuroinflammation; 2007 Sep; 4():23. PubMed ID: 17880684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease.
    Kim BW; Koppula S; Kumar H; Park JY; Kim IW; More SV; Kim IS; Han SD; Kim SK; Yoon SH; Choi DK
    Neuropharmacology; 2015 Oct; 97():46-57. PubMed ID: 25983275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglial TNF-α mediates enhancement of dopaminergic degeneration by brain angiotensin.
    Borrajo A; Rodriguez-Perez AI; Diaz-Ruiz C; Guerra MJ; Labandeira-Garcia JL
    Glia; 2014 Jan; 62(1):145-57. PubMed ID: 24272709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspase inhibitors attenuate 1-methyl-4-phenylpyridinium toxicity in primary cultures of mesencephalic dopaminergic neurons.
    Bilsland J; Roy S; Xanthoudakis S; Nicholson DW; Han Y; Grimm E; Hefti F; Harper SJ
    J Neurosci; 2002 Apr; 22(7):2637-49. PubMed ID: 11923429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation.
    Liu Y; Qin L; Li G; Zhang W; An L; Liu B; Hong JS
    J Pharmacol Exp Ther; 2003 Apr; 305(1):212-8. PubMed ID: 12649371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible role of propofol's cyclooxygenase-inhibiting property in alleviating dopaminergic neuronal loss in the substantia nigra in an MPTP-induced murine model of Parkinson's disease.
    Kubo K; Inada T; Shingu K
    Brain Res; 2011 Apr; 1387():125-33. PubMed ID: 21376018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MPP+-induced COX-2 activation and subsequent dopaminergic neurodegeneration.
    Wang T; Pei Z; Zhang W; Liu B; Langenbach R; Lee C; Wilson B; Reece JM; Miller DS; Hong JS
    FASEB J; 2005 Jul; 19(9):1134-6. PubMed ID: 15845609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat shock protein 60: an endogenous inducer of dopaminergic cell death in Parkinson disease.
    Noelker C; Morel L; Osterloh A; Alvarez-Fischer D; Lescot T; Breloer M; Gold M; Oertel WH; Henze C; Michel PP; Dodel RC; Lu L; Hirsch EC; Hunot S; Hartmann A
    J Neuroinflammation; 2014 May; 11():86. PubMed ID: 24886419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.